RECRUITING

Aim 3, Optimizing CRC Screening in Patients With Diabetes in Safety-net Primary Care Settings

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This mixed methods study evaluates the effectiveness and feasibility of a multi-level (patient, team, organizations) intervention to optimize CRC screening for patients with diabetes in primary care safety-net settings.

Official Title

Optimizing Colorectal Cancer Screening Among Patients With Diabetes in Safety-Net Primary Care Settings: Targeting Implementation Approaches

Quick Facts

Study Start:2022-11-01
Study Completion:2025-09-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05785780

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:50 Years to 74 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Diagnosis of diabetes mellitus;
  2. * Participants not up-to-date with CRC screening based on electronic health record (e.g. FOBT/FIT in last year; flexible sigmoidoscopy within four years; or colonoscopy within nine years);
  3. * Age-eligible for CRC screening (50-74 years of age);
  4. * Participants in process of undergoing screening are eligible for participation if they have a FIT/FOBT incomplete test ordered for more than six months or a sigmoidoscopy or colonoscopy referral not completed for greater than one year.
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Denalee O'Malley, PhD
CONTACT
848-319-0004
omalledm@rwjms.rutgers.edu
Cilgy Abraham
CONTACT
732-235-5965
cma182@rwjms.rutgers.edu

Principal Investigator

Denalee O'Malley, PhD
PRINCIPAL_INVESTIGATOR
Rutgers Robert Wood Johnson Medical School; Rutgers Cancer Institute of New Jersey

Study Locations (Sites)

RWJBarnabas Health - Robert Wood Johnson University Hospital
New Brunswick, New Jersey, 08903
United States

Collaborators and Investigators

Sponsor: Rutgers, The State University of New Jersey

  • Denalee O'Malley, PhD, PRINCIPAL_INVESTIGATOR, Rutgers Robert Wood Johnson Medical School; Rutgers Cancer Institute of New Jersey

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-11-01
Study Completion Date2025-09-30

Study Record Updates

Study Start Date2022-11-01
Study Completion Date2025-09-30

Terms related to this study

Additional Relevant MeSH Terms

  • Colorectal Cancer Screening
  • Diabetes Mellitus, Type 2